August 12, 2020
Issue PDF
40
8
Click here for a link to open the Pharmaceutical Executive August 2020 issue in an interactive PDF format.
August 11, 2020
Features
40
8
Our latest review of biopharma financial performance reveals solid growth rates in enterprise value and rebounding value-to-sales numbers—proving once again the business imperative of regaining and sustaining shareholder value.
August 11, 2020
Columns
40
8
Should therapies and vaccines be cheap or free in a pandemic and would that really dry up innovation?
August 11, 2020
Columns
40
8
How one COVID-sparked model could help usher in needed reset.
August 10, 2020
Features
40
8
How pharma leaders can convert data collected for compliance purposes from a cost center into a critical success factor.
August 10, 2020
From the Editor
40
8
How “Contractual Genericization” could revitalize pharma and reframe the public conversation.
August 10, 2020
Features
40
8
In adjusting to the long-term aftershocks from the coronavirus pandemic, pharma companies will need to focus on change in three core areas.
August 10, 2020
Features
40
8
Patrick Soon-Shiong, the billionaire biotech entrepreneur and owner of NantWorks, a network of health startups, discusses his companies’ COVID-19 vaccine candidate and its “fighting chance” to outsmart the virus’s hidden tricks through merging supercomputing and modernized DNA delivery.
August 10, 2020
Columns
40
8
Latest reform brouhaha requires a united response focused on real solutions.
August 10, 2020
Features
40
8
While exposing gaps in the way pharma acquires and uses data, the pandemic has also fostered a new spirit of information sharing that bodes well for future collaborations.
August 07, 2020
Columns
40
8
Collaboratives, company initiatives address systemic barriers.
August 07, 2020
Columns
40
8
The need for clear transparency around use of real-world data, AI.
August 07, 2020
Columns
40
8
Their application for security and anti-counterfeiting purposes continues to evolve, especially in combination with digital technology.
August 07, 2020
Columns
40
8
Budget battle threatens efforts to bolster Europe’s pharma strategy.